Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R

Benton, CB; Khan, M; Sallman, D; Nazha, A; Gonzalez, GMN; Piao, J; Ning, J; Aung, F; Al Ali, N; Jabbour, E; Kadia, TM; Borthakur, G; Ravandi, F; Pierce, S; Steensma, D; DeZern, A; Roboz, G; Sekeres, M; Andreeff, M; Kantarjian, H; Komrokji, RS; Garcia

Garcia-Manero, G (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd Unit 428, Houston, TX 77030 USA.

AMERICAN JOURNAL OF HEMATOLOGY, 2018; 93 (10): 1245

Abstract

The International Prognostic Scoring System-Revised (IPSS-R) is one standard for myelodysplastic syndrome (MDS) risk stratification. It divides patien......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索